Latest Capital Raising News

Page 102 of 536
TerraCom Limited has announced a partially underwritten renounceable entitlement offer aiming to raise approximately A$60 million to bolster its financial position amid ongoing coal price pressures. Key directors have committed to participate, while substantial shareholder Orbit Marketing stands ready to underwrite a significant portion of any shortfall.
Maxwell Dee
Maxwell Dee
23 Dec 2025
TerraCom Limited confirms stable mining operations at Blair Athol despite logistical hurdles, while launching a A$60 million capital raise to bolster liquidity amid shipment timing challenges.
Maxwell Dee
Maxwell Dee
23 Dec 2025
ActivEX Limited has completed a $100,000 share placement with Business Victor Investments Limited, aiming to accelerate its exploration activities and strengthen working capital.
Maxwell Dee
Maxwell Dee
23 Dec 2025
Corella Resources has completed the first tranche of a $1 million share placement, issuing over 142 million shares at $0.0035 each. The second tranche and attached options await shareholder approval in early 2026.
Maxwell Dee
Maxwell Dee
23 Dec 2025
InhaleRx Limited has successfully closed its entitlement offer and placement, raising $857,730 to support the clinical development of inhaled treatments targeting cancer pain and mental health conditions.
Ada Torres
Ada Torres
23 Dec 2025
Pure Resources has completed a $1.7 million placement to fund its Garnet Hills Garnet and Graphite Project, with options to be issued pending shareholder approval.
Maxwell Dee
Maxwell Dee
23 Dec 2025
DevEx Resources has successfully raised nearly $7 million through an oversubscribed Share Purchase Plan, significantly exceeding its initial $3 million target to fund expanded uranium exploration in Australia’s Northern Territory.
Maxwell Dee
Maxwell Dee
23 Dec 2025
Wingara AG Limited has arranged a $250,000 unsecured loan facility from NAOS Asset Management entities, featuring a convertible note option that could reshape its capital structure.
Ada Torres
Ada Torres
23 Dec 2025
American Tungsten & Antimony Ltd plans to unlock value by spinning out its Drummond Basin and NSW gold exploration assets into a new ASX-listed company, King Metals Limited, aiming to raise up to $6 million in an IPO.
Maxwell Dee
Maxwell Dee
23 Dec 2025
Chimeric Therapeutics has raised $8.4 million to fully fund its lead CHM CDH17 CAR-T Phase 1/2 trial through Phase 1, while initiating a strategic reset to sharpen focus and reduce costs.
Ada Torres
Ada Torres
23 Dec 2025
Neurizon Therapeutics has launched a A$24.2 million equity raise to fund the next phase of clinical trials for its lead drug NUZ-001 targeting ALS, supported by a global licensing deal and a flexible convertible note facility.
Ada Torres
Ada Torres
23 Dec 2025
Neurizon Therapeutics has locked in a $44 million funding package to fully support its lead drug NUZ-001 in the HEALEY ALS Platform Trial, marking a critical step toward potential regulatory approval and broader neurodegenerative applications.
Ada Torres
Ada Torres
23 Dec 2025